NICERespiratory Medicine2021Updated 2021
NICE Asthma: Diagnosis, Monitoring and Chronic Asthma Management 2021
Published by National Institute for Health and Care Excellence · 52 pages · Class I–II
RecommendedFeNO diagnostic
Step 3MART threshold
Not recommendedSABA only
Summary
Free previewUpdated NICE asthma guidance endorses FeNO testing in the diagnostic pathway and recommends MART (Maintenance and Reliever Therapy) with ICS-formoterol as preferred treatment for adults with uncontrolled asthma on low-dose ICS. Removes SABA-only prescribing from first-line.
AsthmaICSMART therapyFeNOSABAFormoterol
Key Recommendations
Evidence Grading & Drug Doses
What's New vs Previous Version
Implementation & Clinical Pearls
Full guideline access requires an account
Create a free Prognia account to read the complete guideline — including all recommendations, evidence tables, drug dosing, and clinical pearls.
Full guideline text with all recommendations
Evidence grades (Class I/II/III, Level A/B/C)
AI-generated summary and clinical pearls
Auto-logged as CPD/CME activity
Free plan includes 10 guideline reads per day · No credit card required